These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32379878)

  • 61. SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
    Voronkova MA; Luanpitpong S; Rojanasakul LW; Castranova V; Dinu CZ; Riedel H; Rojanasakul Y
    Sci Rep; 2017 Sep; 7(1):11653. PubMed ID: 28912540
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance.
    Chen J; Ding P; Li L; Gu H; Zhang X; Zhang L; Wang N; Gan L; Wang Q; Zhang W; Hu W
    Stem Cell Reports; 2017 Jan; 8(1):140-151. PubMed ID: 28017655
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity.
    Palanichamy K; Jacob JR; Litzenberg KT; Ray-Chaudhury A; Chakravarti A
    EBioMedicine; 2018 Oct; 36():281-292. PubMed ID: 30269995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Patient-derived xenograft models-the future of personalised cancer treatment.
    Bhimani J; Ball K; Stebbing J
    Br J Cancer; 2020 Mar; 122(5):601-602. PubMed ID: 31919403
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.
    Wiekmeijer AS; Pike-Overzet K; IJspeert H; Brugman MH; Wolvers-Tettero IL; Lankester AC; Bredius RG; van Dongen JJ; Fibbe WE; Langerak AW; van der Burg M; Staal FJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):517-526.e3. PubMed ID: 26441229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Testing PARP Inhibitors Using a Murine Xenograft Model.
    Makhov P; Naito S; Kolenko VM
    Methods Mol Biol; 2017; 1608():313-320. PubMed ID: 28695518
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies.
    Bagby S; Messersmith WA; Pitts TM; Capasso A; Varella-Garcia M; Klauck PJ; Kim J; Tan AC; Eckhardt SG; Tentler JJ; Arcaroli J
    J Vis Exp; 2016 Sep; (115):. PubMed ID: 27768028
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Use of Peripheral Extracellular Vesicles for Identification of Molecular Biomarkers in a Solid Tumor Mouse Model.
    García-Romero N; Rackov G; Belda-Iniesta C; Ayuso-Sacido Á
    Methods Mol Biol; 2017; 1660():397-406. PubMed ID: 28828675
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
    Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
    Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
    [No Abstract]   [Full Text] [Related]  

  • 71. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors.
    Nolta JA; Thiemann FT; Arakawa-Hoyt J; Dao MA; Barsky LW; Moore KA; Lemischka IR; Crooks GM
    Leukemia; 2002 Mar; 16(3):352-61. PubMed ID: 11896538
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Establishing metastatic patient-derived xenograft model for colorectal cancer.
    Zhang Y; Lee SH; Wang C; Gao Y; Li J; Xu W
    Jpn J Clin Oncol; 2020 Sep; 50(10):1108-1116. PubMed ID: 32579167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
    Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
    Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.
    Gholamin S; Mitra SS; Feroze AH; Liu J; Kahn SA; Zhang M; Esparza R; Richard C; Ramaswamy V; Remke M; Volkmer AK; Willingham S; Ponnuswami A; McCarty A; Lovelace P; Storm TA; Schubert S; Hutter G; Narayanan C; Chu P; Raabe EH; Harsh G; Taylor MD; Monje M; Cho YJ; Majeti R; Volkmer JP; Fisher PG; Grant G; Steinberg GK; Vogel H; Edwards M; Weissman IL; Cheshier SH
    Sci Transl Med; 2017 Mar; 9(381):. PubMed ID: 28298418
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Humanized model for acute myeloid leukemia].
    Ishikawa F
    Nihon Rinsho; 2009 Oct; 67(10):1984-90. PubMed ID: 19860202
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Animal models for the study of cancer stem cells].
    Guasch G
    Bull Cancer; 2017 Dec; 104(12):1064-1067. PubMed ID: 29157554
    [No Abstract]   [Full Text] [Related]  

  • 78. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
    Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
    Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation.
    van den Berg TK; van der Schoot CE
    Trends Immunol; 2008 May; 29(5):203-6. PubMed ID: 18394962
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
    Binsfeld M; Hannon M; Otjacques E; Humblet-Baron S; Baudoux E; Beguin Y; Baron F; Caers J
    Cancer Immunol Immunother; 2015 Aug; 64(8):989-98. PubMed ID: 25971542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.